Mountain View, CA (PRWEB) March 10, 2014
ARA announces the appointment of Robert Stemplinger as Sr. Director, Programming and Data Standards. Mr. Stemplinger will report directly to Peter Shabe, ARA’s President and CEO.
Mr. Stemplinger joins ARA from a 16-year period with ICON Clinical Research, where he most recently served as Senior Director, Statistical Programming, and previously as Senior Director, Data Integration and Standardization, and as Senior Director, Data Management and Applications Programming. Mr. Stemplinger has held senior management or management positions for various public and private companies in the biotechnology and pharmaceutical industry over the past 23 years, with emphasis on statistical programming, clinical data management, applications development, and project management. Recent focus has been on CDISC standards, including heading a department responsible for implementing the solution for creating SDTM and ADaM data sets and their associated deliverables. Mr. Stemplinger holds a B.S. in Mathematics from California Polytechnic State University, San Luis Obispo, CA and is the author of numerous publications and presentations.
“We are excited by Robert’s appointment to the senior management team at ARA,” says Peter Shabe, President. “His extensive experience in all aspects of clinical trials, combined with his departmental management experience, will ensure ARA’s continued enhancement of our CDISC standards. With his responsibility for final implementation of end-to-end standards solutions across Data Management, Biostatistics, and Programming, we view Robert as an integral part in providing our clients with customized services that exceed their expectations.”
For additional information on ARA’s CRO services and our experienced team of professionals, visit: http://www.advanceresearch.com.
About ARA
Advance Research Associates, Inc. (ARA) is a privately held company that has been providing comprehensive data management and biostatistical reporting services to the pharmaceutical, biotech, and medical device industries since 1996. Since its inception, ARA has supported over 400 clinical studies for over 200 companies in their clinical programs to bring their products to market in the US, Europe, Japan, and Pan-Pacific countries.